Your browser doesn't support javascript.
loading
A Pyrazolate Osmium(VI) Nitride Exhibits Anticancer Activity through Modulating Protein Homeostasis in HepG2 Cells.
Huang, Chengyang; Huang, Wanqiong; Ji, Pengchao; Song, Fuling; Liu, Tao; Li, Meiyang; Guo, Hongzhi; Huang, Yongliang; Yu, Cuicui; Wang, Chuanxian; Ni, Wenxiu.
Afiliação
  • Huang C; Department of Physiology, Shantou University Medical College, Shantou 515041, China.
  • Huang W; Department of Biological Chemistry, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
  • Ji P; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
  • Song F; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
  • Liu T; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
  • Li M; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
  • Guo H; Department of Physiology, Shantou University Medical College, Shantou 515041, China.
  • Huang Y; Department of Physiology, Shantou University Medical College, Shantou 515041, China.
  • Yu C; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
  • Wang C; Department of Physiology, Shantou University Medical College, Shantou 515041, China.
  • Ni W; Department of Medicinal Chemistry, Shantou University Medical College, Shantou 515041, China.
Int J Mol Sci ; 23(21)2022 Oct 24.
Article em En | MEDLINE | ID: mdl-36361570

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osmio / Antineoplásicos Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osmio / Antineoplásicos Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China